down arrow

Hester Bios

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE782E01017
  • NSEID: HESTERBIO
  • BSEID: 524669
INR
1,666.85
68.85 (4.31%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 6.4 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,611.901,666.85

52 Week

1,246.753,375.45
Valuation
Technical
Day's Volume

CASH

6.4 k (-88.69%) Volume

Shareholding (Mar 2025)

FII

0.87%

Held by 20 FIIs

DII

0.02%

Held by 0 DIIs

Promoter

53.73%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.36 times

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.36 times
2

Poor long term growth as Operating profit has grown by an annual rate -4.76% of over the last 5 years

 
3

Stock is technically in a Bearish range

4

With ROCE of 8.9, it has a Very Expensive valuation with a 3 Enterprise value to Capital Employed

5

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,409 Cr (Small Cap)

stock-summary
P/E

44.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.38%

stock-summary
Debt Equity

0.75

stock-summary
Return on Equity

7.78%

stock-summary
Price to Book

4.50

Revenue and Profits (1 Year):
Net Sales:
63 Cr
(Quarterly Results - Dec 2024)
Net Profit:
12 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.38%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-29.14%
0%
-29.14%
1 Year
4.82%
0.35%
5.17%
2 Years
-0.25%
0.79%
0.54%
3 Years
-40.8%
1.03%
-39.77%
4 Years
-24.48%
1.16%
-23.32%
5 Years
59.61%
3.53%
63.14%

Latest dividend: 6 per share ex-dividend date: Aug-22-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
9.96%
EBIT Growth (5y)
-4.76%
EBIT to Interest (avg)
5.47
Debt to EBITDA (avg)
3.58
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.55
Tax Ratio
26.30%
Dividend Payout Ratio
27.02%
Pledged Shares
0
Institutional Holding
0.89%
ROCE (avg)
10.65%
ROE (avg)
11.89%
Valuation key factors
Factor
Value
P/E Ratio
44
Industry P/E
33
Price to Book Value
4.50
EV to EBIT
38.30
EV to EBITDA
27.46
EV to Capital Employed
3.00
EV to Sales
5.14
PEG Ratio
0.64
Dividend Yield
0.38%
ROCE (Latest)
8.89%
ROE (Latest)
7.78%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 20 FIIs (0.87%)

Promoter with highest holding

Rajiv Dinesh Gandhi (10.47%)

Highest Public shareholder

Kuntal Hasmukhlal Shah (3.17%)

Individual Investors Holdings

32.64%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -5.61% vs -10.62% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 192.96% vs -64.43% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "63.22",
          "val2": "66.98",
          "chgp": "-5.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.06",
          "val2": "10.15",
          "chgp": "-50.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "-3.81",
          "val2": "2.19",
          "chgp": "-273.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11.66",
          "val2": "3.98",
          "chgp": "192.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.00%",
          "val2": "15.15%",
          "chgp": "-7.15%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 4.83% vs 27.82% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 45.98% vs -8.71% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "165.96",
          "val2": "158.31",
          "chgp": "4.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "36.82",
          "val2": "27.58",
          "chgp": "33.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.90",
          "val2": "10.64",
          "chgp": "2.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.54",
          "val2": "9.96",
          "chgp": "45.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.19%",
          "val2": "17.42%",
          "chgp": "4.77%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 1.73% vs 13.33% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 87.95% vs -36.92% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "229.18",
          "val2": "225.29",
          "chgp": "1.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "41.88",
          "val2": "37.73",
          "chgp": "11.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.09",
          "val2": "12.83",
          "chgp": "-44.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.20",
          "val2": "13.94",
          "chgp": "87.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.27%",
          "val2": "16.75%",
          "chgp": "1.52%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 14.45% vs 13.22% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -29.06% vs -32.27% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "304.55",
          "val2": "266.09",
          "chgp": "14.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "53.65",
          "val2": "50.61",
          "chgp": "6.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.78",
          "val2": "9.32",
          "chgp": "112.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18.89",
          "val2": "26.63",
          "chgp": "-29.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.62%",
          "val2": "19.02%",
          "chgp": "-1.40%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
63.22
66.98
-5.61%
Operating Profit (PBDIT) excl Other Income
5.06
10.15
-50.15%
Interest
-3.81
2.19
-273.97%
Exceptional Items
0.00
0.00
Consolidate Net Profit
11.66
3.98
192.96%
Operating Profit Margin (Excl OI)
8.00%
15.15%
-7.15%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is -5.61% vs -10.62% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 192.96% vs -64.43% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
165.96
158.31
4.83%
Operating Profit (PBDIT) excl Other Income
36.82
27.58
33.50%
Interest
10.90
10.64
2.44%
Exceptional Items
0.00
0.00
Consolidate Net Profit
14.54
9.96
45.98%
Operating Profit Margin (Excl OI)
22.19%
17.42%
4.77%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 4.83% vs 27.82% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 45.98% vs -8.71% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
229.18
225.29
1.73%
Operating Profit (PBDIT) excl Other Income
41.88
37.73
11.00%
Interest
7.09
12.83
-44.74%
Exceptional Items
0.00
0.00
Consolidate Net Profit
26.20
13.94
87.95%
Operating Profit Margin (Excl OI)
18.27%
16.75%
1.52%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 1.73% vs 13.33% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 87.95% vs -36.92% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
304.55
266.09
14.45%
Operating Profit (PBDIT) excl Other Income
53.65
50.61
6.01%
Interest
19.78
9.32
112.23%
Exceptional Items
0.00
0.00
Consolidate Net Profit
18.89
26.63
-29.06%
Operating Profit Margin (Excl OI)
17.62%
19.02%
-1.40%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 14.45% vs 13.22% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -29.06% vs -32.27% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Hester Biosciences Ltd stock-summary
stock-summary
Hester Biosciences Ltd
Small Cap
Pharmaceuticals & Drugs
Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India. The Company was incorporated in April, 1987 and is principally engaged in manufacturing of Poultry vaccines and Large Animal Vaccines and trading of Poultry and Large animal and Petcare health products having its manufacturing set up at Meda Adraj Village, Mehsana District, Gujarat. The Company engages in two business verticals, namely Poultry Healthcare and Animal Healthcare.
Company Coordinates stock-summary
Company Details
1st Flr PushpakPachvati Circle, Motilal Hirabhai Road Ahmedabad Gujarat : 380006
stock-summary
Tel: 91-079-26445107
stock-summary
http://www.hester.in
stock-summary
mail@hester.in
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."